Live Better With Blog

A new treatment for leukaemia developed in Australia has been fast-tracked for use in the US and EU. The drug Venetoclax is a targeted therapy designed to prevent the perpetual growth and replication of cancer cells.

By blocking BCL2, a protein produced by cancer cells making them immortal, Venetoclax stops the cells from being able ...

Cancer drug companies drop prices to get NHS approval

Tougher negotiations with pharmaceutical firms means the NHS can now benefit from cheaper cancer drugs. This comes as a much needed  relief to patients after closure of the Cancer Drug Fund, worth £340 million per year.

In order for the NHS to provide a drug free, of charge, to the nation it must first decide ...

Immunotherapy: Cancer’s newest treatment

After Karen Koehler’s cancer took a turn for the worse in 2013 she was given 10 months to live and with gruelling rounds of chemotherapy she could hope to stretch it to 2 years. Luckily, Koehler was enrolled in an immunotherapy trial at Memorial Sloan Kettering Cancer Center in New York. The trial succeeded in ...

Major blood cancer is 11 distinct diseases

Acute Myeloid Leukaemia (AML) is a common type of blood cancer affecting 3,000 new patients per year in the UK. It is often very aggressive, especially in older populations, with a 5 year survival rate of 20%. Treatment involves chemotherapy and stem cell transplantation, however it is very difficult to know which patients will respond well and which may not. In a new study by Dr Peter Campbell from the Wellcome Trust Sanger Institute and Dr Elli Papaemmanuil, who co-authored the study, have shown that AML is in fact 11 different diseases and that identifying patients according to this new sub classification can have a far more reliable prediction of treatment outcomes.